Prospective Survey of Menstrual Migraine & Prevention With Eletriptan
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Women are followed prospectively for 3 months, recording headaches, other symptoms, and
menstrual periods. Those with menstrual migraine are treated perimenstrually with eletriptan
for 3 months.